Nichole T Tanner1, Leonard E Egede2, Clayton Shamblin3, Mulugeta Gebregziabher4, Gerard A Silvestri3. 1. Center for Disease Prevention and Health Interventions for Diverse Populations, Charleston VA Research Enhancement Award Program, Ralph H. Johnson VA Medical Center, Charleston, SC; Division of Pulmonary and Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston. Electronic address: tripici@musc.edu. 2. Center for Disease Prevention and Health Interventions for Diverse Populations, Charleston VA Research Enhancement Award Program, Ralph H. Johnson VA Medical Center, Charleston, SC; Center for Health Disparities Research, Medical University of South Carolina, Charleston; Division of Internal Medicine and Geriatrics, Department of Internal Medicine, Medical University of South Carolina, Charleston. 3. Division of Pulmonary and Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston. 4. Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston.
Abstract
BACKGROUND: Lung cancer (LC) is the leading cause of cancer-related death for veterans cared for by the US Veterans Health Administration. The LC burden among veterans is almost double that of the general population. Before implementation of an LC screening program, we set out to assess the role of beliefs and attitudes toward LC screening among veterans. METHODS: Veterans presenting to the Ralph H. Johnson VA Medical Center were invited to complete a self-administered survey. The survey comprised questions about demographics, smoking status, health status, and knowledge about LC and willingness to be screened. Responses from veteran ever and never smokers were compared. RESULTS: A total of 209 veterans completed the survey. Smokers were significantly (P < .05) more likely than never smokers to be less educated, have a lower income, and report poorer health. Smokers were more likely than never smokers to have two or more comorbidities, which trended toward significance (P = .062). Smokers were more likely to have been told by a physician that they were at high risk for LC and to believe that they were at risk. Nearly all veterans surveyed (92.8%) would have a CT scan for LC screening, and 92.4% would have surgery for a screen-detected LC. CONCLUSIONS: Veterans are overwhelmingly willing to undergo screening for LC, and it seems that participation will not be a barrier to implementation of an LC screening program. The mortality benefit of LC screening, however, may not be generalizable to the veteran population because of a higher number of comorbid conditions.
BACKGROUND:Lung cancer (LC) is the leading cause of cancer-related death for veterans cared for by the US Veterans Health Administration. The LC burden among veterans is almost double that of the general population. Before implementation of an LC screening program, we set out to assess the role of beliefs and attitudes toward LC screening among veterans. METHODS: Veterans presenting to the Ralph H. Johnson VA Medical Center were invited to complete a self-administered survey. The survey comprised questions about demographics, smoking status, health status, and knowledge about LC and willingness to be screened. Responses from veteran ever and never smokers were compared. RESULTS: A total of 209 veterans completed the survey. Smokers were significantly (P &lt; .05) more likely than never smokers to be less educated, have a lower income, and report poorer health. Smokers were more likely than never smokers to have two or more comorbidities, which trended toward significance (P = .062). Smokers were more likely to have been told by a physician that they were at high risk for LC and to believe that they were at risk. Nearly all veterans surveyed (92.8%) would have a CT scan for LC screening, and 92.4% would have surgery for a screen-detected LC. CONCLUSIONS: Veterans are overwhelmingly willing to undergo screening for LC, and it seems that participation will not be a barrier to implementation of an LC screening program. The mortality benefit of LC screening, however, may not be generalizable to the veteran population because of a higher number of comorbid conditions.
Authors: Sirisha Jonnalagadda; Cara Bergamo; Jenny J Lin; Linda Lurslurchachai; Michael Diefenbach; Cardinale Smith; Judith E Nelson; Juan P Wisnivesky Journal: Lung Cancer Date: 2012-06-06 Impact factor: 5.705
Authors: Barbara G Campling; Wei-Ting Hwang; Jiameng Zhang; Stephanie Thompson; Leslie A Litzky; Anil Vachani; Ilene M Rosen; Kenneth M Algazy Journal: Cancer Date: 2005-08-15 Impact factor: 6.860
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky Journal: J Natl Cancer Inst Date: 2010-11-22 Impact factor: 13.506
Authors: Mitchell L Margolis; Jason D Christie; Gerard A Silvestri; Larry Kaiser; Silverio Santiago; John Hansen-Flaschen Journal: Ann Intern Med Date: 2003-10-07 Impact factor: 25.391
Authors: R M Klevens; G A Giovino; J P Peddicord; D E Nelson; P Mowery; L Grummer-Strawn Journal: Am J Prev Med Date: 1995 Jul-Aug Impact factor: 5.043
Authors: James Simmons; Michael K Gould; Steven Woloshin; Lisa M Schwartz; Renda Soylemez Wiener Journal: Am J Respir Crit Care Med Date: 2015-02-15 Impact factor: 21.405
Authors: John Monu; Matthew Triplette; Douglas E Wood; Erika M Wolff; Danielle C Lavallee; David R Flum; Farhood Farjah Journal: Chest Date: 2020-02-07 Impact factor: 9.410
Authors: Andrea N Burnett-Hartman; Nikki M Carroll; Stacey A Honda; Caroline Joyce; Nandita Mitra; Christine Neslund-Dudas; Oluwatosin Olaiya; Katharine A Rendle; Mitchell D Schnall; Anil Vachani; Debra P Ritzwoller Journal: Ann Am Thorac Soc Date: 2022-03